These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9988740)
1. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. Hamik A; Setiadi H; Bu G; McEver RP; Morrissey JH J Biol Chem; 1999 Feb; 274(8):4962-9. PubMed ID: 9988740 [TBL] [Abstract][Full Text] [Related]
2. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255 [TBL] [Abstract][Full Text] [Related]
3. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. Sevinsky JR; Rao LV; Ruf W J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163 [TBL] [Abstract][Full Text] [Related]
4. The low density lipoprotein receptor-related protein can function independently from heparan sulfate proteoglycans in tissue factor pathway inhibitor endocytosis. Warshawsky I; Herz J; Broze GJ; Schwartz AL J Biol Chem; 1996 Oct; 271(42):25873-9. PubMed ID: 8824219 [TBL] [Abstract][Full Text] [Related]
5. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus. El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770 [TBL] [Abstract][Full Text] [Related]
7. Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Hansen CB; Pyke C; Petersen LC; Rao LV Blood; 2001 Mar; 97(6):1712-20. PubMed ID: 11238112 [TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. Ho G; Toomey JR; Broze GJ; Schwartz AL J Biol Chem; 1996 Apr; 271(16):9497-502. PubMed ID: 8621621 [TBL] [Abstract][Full Text] [Related]
10. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain. Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595 [TBL] [Abstract][Full Text] [Related]
11. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Warshawsky I; Broze GJ; Schwartz AL Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6664-8. PubMed ID: 7517557 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition. Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177 [TBL] [Abstract][Full Text] [Related]
13. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes. Thiec F; Cherel G; Christophe OD J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. Rao LV; Ruf W Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667 [TBL] [Abstract][Full Text] [Related]
16. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388 [TBL] [Abstract][Full Text] [Related]
17. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987 [TBL] [Abstract][Full Text] [Related]
18. Direct inhibition of factor VIIa by TFPI and TFPI constructs. Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M J Thromb Haemost; 2013 Apr; 11(4):704-14. PubMed ID: 23347185 [TBL] [Abstract][Full Text] [Related]
19. Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis. Rao LV; Pendurthi UR Mol Cell Biochem; 2003 Nov; 253(1-2):131-40. PubMed ID: 14619963 [TBL] [Abstract][Full Text] [Related]
20. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). Dockal M; Hartmann R; Fries M; Thomassen MC; Heinzmann A; Ehrlich H; Rosing J; Osterkamp F; Polakowski T; Reineke U; Griessner A; Brandstetter H; Scheiflinger F J Biol Chem; 2014 Jan; 289(3):1732-41. PubMed ID: 24275667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]